About this trial
Unregulated opioids remain a leading driver of preventable mortality and potential years of life lost in Canada. Emergency departments (EDs)-open 24/7 and frequently accessed by people who use drugs-offer critical opportunities to reverse toxicity, mitigate harm, and initiate treatment. Yet, high quality evidence to guide ED care for patients with opioid poisoning and concomitant opioid dependence or opioid use disorder is limited. The investigators aim to establish a pan Canadian registry of patients presenting to EDs with opioid poisoning to generate timely, practice informing evidence. The investigators will create the Canadian Emergency Department Research Network (CEDRN) Opioid Registry across participating EDs nationwide. Using automated screening of electronic health records (EHRs), the investigators will identify consecutive patients of all ages with suspected or confirmed opioid poisoning at their index ED visit. The project's objectives are to establish a pan-Canadian registry of Emergency Department patients presenting with opioid poisoning, harmonize data collection across participating sites, describe variations in patient characteristics, clinical practice and outcomes, and derive a clinical decision rule to predict the risk of dying within 60 days. The expected outcomes include advancing healthcare delivery, improving patient and provider experiences, and enhancing population health and health system sustainability for individuals with opioid poisoning. This research is crucial for addressing the opioid crisis in Canada and has the potential to significantly impact patient care and outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Percocet Overdose
Oxycontin Overdose
Oxycodone Overdose
Opioid Overdose or Intoxication
Disqualifiers
None
Trial population
All patients presenting to any one of the Canadian Emergency Department Research Network's emergency department, and meeting the inclusion criteria.
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Proportion of patients who received opioid agonist therapy (methadone, buprenorphine/naloxone, extended release buprenorphine injection, slow-release oral morphine).
Number of patients that were administered any of the following types of opioid agonist therapy during their visit to the emergency department.
Other outcomes
Proportion of patients who left against medical advice.
Percentage of patient leave before being formally discharged from the emergency department, or leaving the emergency department without being seen by a physician.
Proportion of patients hospitalized
Whether the patient was admitted to the hospital after their emergency department visit
Proportion of naloxone administration
Was patient administered during their emergency department visit
Proportion of in-hospital mortality
Number of patients who died in the hospital
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of British Columbia
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator